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Abstract
Collagen 6A3 (Col6a3), a component of extracellular matrix, is often up-regulated in tumours and is believed to play a pro-
oncogenic role. However the mechanisms of its tumorigenic activity are poorly understood. We show here that Col6a3 is
highly expressed in densely growing mouse embryonic fibroblasts (MEFs). In MEFs where the TAF4 subunit of general
transcription factor IID (TFIID) has been inactivated, elevated Col6a3 expression prevents contact inhibition promoting their
3 dimensional growth as foci and fibrospheres. Analyses of gene expression in densely growing Taf42/2 MEFs revealed
repression of the Hippo pathway and activation of Wnt signalling. The Hippo activator Kibra/Wwc1 is repressed under dense
conditions in Taf42/2 MEFs, leading to nuclear accumulation of the proliferation factor YAP1 in the cells forming 3D foci. At
the same time, Wnt9a is activated and the Sfrp2 antagonist of Wnt signalling is repressed. Surprisingly, treatment of Taf42/2
MEFs with all-trans retinoic acid (ATRA) restores contact inhibition suppressing 3D growth. ATRA represses Col6a3
expression independently of TAF4 expression and Col6a3 silencing is sufficient to restore contact inhibition in Taf42/2 MEFs
and to suppress 3D growth by reactivating Kibra expression to induce Hippo signalling and by inducing Sfrp2 expression to
antagonize Wnt signalling. All together, these results reveal a critical role for Col6a3 in regulating both Hippo and Wnt
signalling to promote 3D growth, and show that the TFIID subunit TAF4 is essential to restrain the growth promoting
properties of Col6a3. Our data provide new insight into the role of extra cellular matrix components in regulating cell
growth.
Citation: Martianov I, Cler E, Duluc I, Vicaire S, Philipps M, et al. (2014) TAF4 Inactivation Reveals the 3 Dimensional Growth Promoting Activities of Collagen
6A3. PLoS ONE 9(2): e87365. doi:10.1371/journal.pone.0087365
Editor: Roberto Mantovani, Universita` degli Studi di Milano, Italy
Received July 1, 2013; Accepted December 23, 2013; Published February 3, 2014
Copyright:  2014 Martianov et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: This work was supported by grants from the CNRS, the INSERM, the Association pour la Recherche contre le Cancer, the Ligue Nationale et
De´partementale Re´gion Alsace contre le Cancer and in Institut National du Cancer (INCa). ID is an ‘e´quipe labellise´e’ of the Ligue Nationale contre le Cancer. EC
was supported by a fellowship from the Fondation pour la Recherche Medicale. The funders had no role in study design, data collection and analysis, decision to
publish, or preparation of the manuscript.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: irwin@igbmc.fr (IM); martiano@igbmc.fr (ID)
. These authors contributed equally to this study
Introduction
TAF4 is a subunit of the general transcription factor TFIID. In
vertebrates, the TAF4 family comprises a ubiquitously expressed
TAF4 protein and a tissue specific paralogue, TAF4b, required for
testis and ovary function [1,2]. To address the function of
mammalian TAF4, we previously inactivated TAF4 in the adult
mouse epidermis where its loss results in enhanced EGF signalling
and increased keratinocyte proliferation [3]. Inactivation of TAF4
also leads to malignant transformation of chemically induced
papillomas and the appearance of invasive melanocytic tumours.
Thus, TAF4 acts as a tumour suppressor in the epidermis. We also
have generated Taf4lox/2 and Taf42/2 mouse embryonic fibro-
blasts (MEFs). In Taf4lox/2 MEFs the TFIID contains predomi-
nantly TAF4, whereas in Taf42/2 MEFs, TAF4b replaces TAF4
to maintain TFIID integrity and cell viability [4]. TAF4-
containing and TAF4b-containing TFIIDs have different proper-
ties as Taf42/2 MEFs display TGFb-dependent autocrine growth
and deregulated expression of more than 1000 genes.
Contact inhibition is a process that arrests cell proliferation
upon cellular contacts under conditions of high density. It is an
important mechanism of anti-cancer defence, as tumour cells
normally lose this property and grow in an uncontrolled manner.
The molecular mechanisms underlying contact inhibition are still
poorly understood. A number of recent studies identified the
Hippo signalling pathway as a major effector of contact inhibition
[5–7]. Activation of the Hippo pathway leads to phosphorylation
of the YAP1 and WWTR1/TAZ coactivators by the LATS1/2
kinases and their export from the nucleus. When Hippo signalling
is attenuated, YAP and TAZ accumulate in the nucleus acting as
coactivators for various transcription factors, such as those of the
TEAD family, that activate genes promoting cell proliferation [8].
In normal cells, Hippo signalling is activated in dense conditions
leading to export of YAP/TAZ from the nucleus and arrest of
proliferation, while in transformed cells lacking contact inhibition
the Hippo signalling pathway is attenuated and YAP/TAZ remain
in the nucleus even under dense conditions to promote cell growth.
Loss of contact inhibition is not the only event in oncogenic
transformation. Other events are required, such as the activation
of the Wnt signalling pathway. This pathway regulates many
biological processes, including morphology, proliferation, motility
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and cell fate. The canonical Wnt pathway involves binding of Wnt
proteins to cell-surface receptors of the Frizzled family, causing the
receptors to activate Dishevelled family proteins and resulting in
stabilization and nuclear import of b-catenin. Inappropriate
activation of this pathway with accumulation of nuclear b-catenin
is observed in several human cancers [9].
It is becoming increasingly recognised that the extracellular
matrix (ECM) not only provides a 3 dimensional (3D) matrix for
cell growth and organogenesis, but that signals from the ECM play
critical roles in cell fate and cell growth [10]. In cancer, the local
microenvironment and especially the ECM also play an important
role in cancer progression. Collagens are the most abundant
proteins in the ECM and Collagen VI has been the focus of
substantial interest due to its association with cancer. Collagen VI
is a large, multidomain ECM protein composed of a triple-helix of
a1, a2, and a3 chains that tetramerise through end-to-end
association and assemble into a microfibrillar network. It was
shown that Collagen VI is up-regulated during murine mammary
tumour progression [11]. Accordingly, the absence of Collagen VI
in a breast cancer-prone mouse strain reduced the rates of early
hyperplasia and primary tumour growth [12]. Similarly, Collagen
VI has been shown to contribute to the resistance of human
ovarian cancer cells to cisplatin treatment and to be up-regulated
in several high grade human tumours [13]. However, despite its
importance, the pathways linking Collagen VI to carcinogenesis
remain poor characterised. Moreover, Collagen VI is also a
component of the ECM in normal tissue, indicating that other
mechanisms may keep in check its oncogenic activity.
Here we show that TAF4 is able to attenuate the growth
promoting activities of Collagen VI. In a Taf42/2 background, a
subpopulation of MEFs loses contact inhibition, resulting in the
formation of 3D foci and growth as fibrospheres. The cells forming
foci are characterised by activated Wnt signalling and inhibition of
Hippo signalling. Strikingly, Col6a3 silencing is sufficient to
restore contact inhibition in Taf42/2 MEFs. Our data show for
the first time that Col6a3 plays a role in modulating signalling
pathways involved in contact inhibition providing an explanation
for the observed association between Col6a3 and cancer. It also
suggests that changes in the ratio of TAF4 and TAF4b can play a
role in the susceptibility of cells to Col6a3-promoted 3D growth.
Finally, we also show that all-trans retinoic acid (ATRA) treatment
represses Col6a3 expression thus abrogating premalignant changes
in both wild-type and Taf42/2 MEFs. Our data suggest that




The C1Taf4lox/2 and C3Taf42/2 MEFs were derived from
genetically modified Taf4lox/2 mouse embryos and have previ-
ously been described [4]. The floxed Taf4 allele was defloxed in
the C1 MEFs by expression of the Cre recombinase and loss of
TAF4 expression in the C3 MEFs was verified by PCR genotyping
and by western blot analysis as described (10). Cells were cultured
in Dulbecco’s minimal essential media (DMEM) supplemented
with 4.5 g/l glucose and 10% foetal calf serum. Cells were treated
with 1026 M ATRA dissolved in ethanol (DMSO) as indicated.
Fibrosphere assays
For fibrosphere assays, the indicated cells were also grown
under non-adherent conditions in bacterial culture plates. 106 of
the indicated cells were inoculated and grown for 10 days.
Immunofluoresence
Immunofluoressence on C1 and C3 cells was performed by
standard procedure using following antibodies: COL6A3
(PAB17517, Abnova), CTNNB1 (Abcam, ab6302, and BD
Biosciences, 610153), YAP1 (Cell Signalling, #4912), TAZ (BD
Bionsciences, 560235), SOX2 (Cell Signalling, #4900). Immuno-
fluorescence was visualized using a Zeiss Axiophot (Carl Zeiss,
Gottingen, Germany) microscope equipped with epifluorescence
illumination. Confocal microscopy was performed on a Leica SP2
microscope.
Wnt signalling inhibitors
IWR-1 (Sigma-Aldrich, I0161) and XAV939 (Sigma-Aldrich,
X3004) were used at 1 mg/mL concentration.
RNA-seq
RNA-seq was performed as previously described [14]. Briefly,
mRNA was purified from 2 mg of total RNA from C3 cells, grown
at low or high densities, as spheres or after 12 and 24 hours of
treatment with ATRA, using oligo-dT magnetic beads and
fragmented using divalent cations at 95uC for 5 minutes. The
cleaved mRNA fragments were reverse transcribed to cDNA using
random primers and SuperScript II reverse transcriptase (#
18064-014, Invitrogen) and second strand cDNA synthesis using
Polymerase I and RNase H. DNA libraries were prepared as
indicated by Illumina and checked for quality and quantified using
2100 Bioanalyzer (Agilent, USA). The libraries were loaded in the
flowcell at 6pM concentration and clusters were generated using
the Cbot and sequenced on the Illumina Genome Analyzer IIx as
single-end 54 base reads following Illumina’s instructions.
Sequence reads mapped to reference genome mm9/NCBI37
using Tophat [15]. Quantification of gene expression was done
using Cufflinks [16] and annotations from Ensembl release 57. For
each transcript the resulting FPKM were converted into raw read
counts and these counts were added for each gene locus. Data
normalization was performed as described by Anders et al. [17]
and implemented in the DESeq Bioconductor package. For the
analysis of gene expression in low vs high-density C3 cells and
fibrospheres, cut off values were, a minimum average RPKM
value of 5, and fold changes $3 or #0.33 with a pvalue of #0,05.
For the analysis of gene expression following retinoic acid
treatment, fold changes $2 or #0.5 were considered along with
a pvalue #0,05.
ShRNA-mediated gene silencing
Lentiviral shRNA expression vectors and packaging plasmids
were purchased from Sigma-Aldrich. The TRC numbers are
indicated in the Supplemental information. Lentiviral particles
were generated by co-transfection of shRNA vector together with
packaging plasmids into 293T cells. Medium was changed 24 hs
after transfection and viruses harvested 48 hs after transfection
and used for infection of C3 cells. Infected C3 cells were selected
with puromycin resistant and silencing of targeted gene was
checked by RT-qPCR.
RT-qPCR
RNA was prepared using Trizol reagent (Invitrogen, 15596-
018) according to manufacturer’s protocol. Reverse transcription
was performed with Super Script II reverse transcriptase
(Invitrogen, 18064-022) as described in manufacture’s protocol.
Random hexaoligonucleotides were used as primers. qPCR was
performed using LightCycler 480 SYBR Green I master mix
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(Roche, 04887352001) on the LightCycler 480 Real-Time PCR
System. List of oligonucleotides is supplied in x S1.
Proliferation assays
For cell counting, 56104 cells were seeded in 10 cm plates. At
the indicated times the cells were trypsinised and counted. BrdU
incorporation was performed using a BrdU Cell Proliferation
Assay kit (QIA58) from Merck/CalBiochem as per the manufac-
turers instructions. Briefly, the cells were grown for the indicated
times with or without RA and then BrdU incorporation for
24 hours was measured by an immuno-colometric assay.
Results
TAF4-null MEFs display 3D growth
We have previously reported generation of Taf42/2 MEFs by
defloxing of Taf4lox/2 MEFs [4]. The Taf42/2 MEFs (hereafter
C3) are irregularly shaped and have lost contact inhibition as they
readily form three dimensional (3D) foci that are never observed
with the Taf4lox/2 MEFs (hereafter C1) (Fig. 1A). We also noted
that whereas the C1 cells did not proliferate in soft agar, the C3
cells formed clearly visible colonies (Fig. 1B).
Many types of transformed cells can be grown under non-
adherent conditions as spheres such as ‘mammospheres’ in the
case of breast cancer cells [18]. We tested the ability of the C3 cells
to grow as ‘fibrospheres’ under non-adherent conditions and found
that they form large round spheres and trabecular structures,
whereas the C1 cells did not develop fibrospheres (Fig. 1C). TAF4
inactivation therefore confers the ability for 3D growth to at least a
subpopulation of C3 MEFs.
Gene expression changes associated with growth at high
density and as fibrospheres
We next used RNA-seq to profile the changes in gene
expression that occur upon 3D growth. RNA was prepared from
low or high-density adherent cultures of C3 cells comprising 3D
foci and from fibrospheres. In comparison with non-confluent
cells, 669 transcripts were-up-regulated and 714 down-regulated in
dense cells (Figs. 2A and B and Table S2). Similarly, in
fibrospheres, 675 transcripts were-up-regulated and 1066 down-
regulated in comparison with non-confluent cells (Figs. 2A and B
and Table S2). A large overlap can be observed amongst
transcripts whose expression is deregulated upon the transition
from the non-confluent to the dense or fibrosphere states. Around
half of the up-regulated genes and a majority of the down-
regulated genes are regulated in common under both the dense
and fibrosphere conditions.
Ontology analysis of the down-regulated transcripts indicated
strong enrichment in those involved in cell cycle and cell division
consistent with the fact that proliferation is considerably reduced
in dense C3 cells or when grown as spheres compared to the rapid
growth of the non-dense cultures (Figs. 2C and D and Table S3).
In contrast, the up-regulated transcripts are enriched in three
distinct classes, those associated with activation of the interferon
(immune) response, apoptosis, and transcripts encoding proteins
involved in modification of adhesion and ECM composition
(Fig. 2E and F). An ontology analysis of the transcripts that are
selectively up-regulated in fibrospheres compared to dense
monolayers also revealed an enrichment in genes associated with
the membrane and ECM, but did not reveal a pathway specific to
this growth state (data not shown).
We had previously reported that genes of the interferon
response were strongly induced in the C3 cells lacking TAF4
compared to the C1 cells. We ascribed this difference to TAF4
inactivation [4]. However, the above results indicate that
activation of the interferon response requires loss of TAF4 and
growth to high density. The presence of a large collection of
apoptosis associated transcripts amongst the up-regulated class
further indicates the presence of a significant number of apoptotic
cells in dense cultures and in fibrospheres. The presence of the
apoptotic cells may be related to activation of the interferon
response genes, since it has been previously established that DNA
Figure 1. 3D growth of C3 cells. A. Phase contrast microscopy (206magnification) of C1 and C3 cells grown as dense cultures for 3 days. B.
Growth of C1 and C3 cells after 10 days in soft agar. C. Phase contrast microscopy (126magnification) of C1 cells or C3 cells in grown for 10 days
under non-adherent conditions.
doi:10.1371/journal.pone.0087365.g001
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from dead cells can induce the interferon response if taken up by
the surrounding cells [19]. However, in the context of this study
we have not further investigated this point.
The gene expression analysis also clearly indicates major
changes in transcripts associated with cell adhesion and the
ECM in dense cultures and spheres. Expression of several
collagens (6a3, 18a1) and laminins (a4 and a5) are strongly
induced along with VCAM1, thrombospondin 2, intergrins b8,
a2b and a7 and cadherins 13 and 26. Thus, 3D growth involves
major changes in cell adhesion and remodelling of the ECM. On
the other hand, expression of Olfm1 and Spp1, although induced in
Figure 2. Changes in gene expression upon 3D growth of C3 cells. A–B Venn diagrammes showing overlapping changes in gene expression
upon growth as dense cultures or fibrospheres. C–F. Ontology analysis (http://david.abcc.ncifcrf.gov/) of the deregulated genes showing some
relevant categories from the CC-FAT and BP FAT classifications. The number of genes and the associated P values for each category are indicated.
doi:10.1371/journal.pone.0087365.g002
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dense C3 cells, is very much higher in fibrospheres (Figs. 3H and
I).
We confirmed the changes in expression of several of the genes
identified by RNA-seq by RT-qPCR in low density C3 cells and
after increasing times in culture to become dense and in
fibrospheres. In agreement with the RNA-seq data, expression of
Col6a3 strongly increases in dense C3 cells and is strongly
expressed in fibrospheres (Fig. 3A). A similar profile was seen
with Sned1, Fgf2, Mgp, Vav3 and the interferon response genes Irf7
and Usp18 (Figs. 3B–G).
Expression of the interferon response genes was not induced in
dense C1 cells and is thus specific to C3 cells. Interestingly
however, expression of several of the ECM-related genes such as
Col6a3 and Sned1 is significantly induced in dense TAF4-expressing
C1 cells showing that their up-regulation is more generally
associated with dense MEF growth and is not specific to the C3
cells (Figs. 3A–C). Strikingly, immunofluorescence using anti-
COL6A3 antibody shows that strong COL6A3 expression in
Taf42/2 MEFs was limited to the cells forming the 3D foci
(Fig. 4A). The surrounding monolayer cells show only weak
labelling. The immunofluorescence signal was lost in cells
expressing shRNAs directed against Col6a3 (see below) demon-
strating its specificity (Fig. 4B and C). Thus, COL6A3 expression is
strongly and selectively up-regulated in the C3 cells that form 3D
foci.
Suppressed Hippo signalling in C3 MEFs
The Hippo signalling pathway is a major player in contact
inhibition where cell-cell contacts activate the pathway to
phosphorylate the YAP1 and WWTR1/TAZ coactivators and
export them from the nucleus of dense cells thereby leading to
arrest of proliferation. Examination of the gene expression profiles
of low vs high density C3 cells and fibrospheres shows no
significant change in the expression of many of the principal
components of this pathway with the notable exception of Kibra
(Wwc1) whose expression is strongly down regulated in dense cells
and fibrospsheres (Table S2). Kibra is an activator of the Hippo
pathway in Drosophila in vivo [20] In mammalian cells, Kibra
associates with and activates the LATS1-2 kinases promoting
YAP1 phosphorylation and its nuclear export [21]. In contrast,
silencing of Kibra expression reduces YAP1 phosphorylation
resulting in nuclear accumulation. We also noted that Fat4
expression was down-regulated in fibrospheres compared to non-
confluent cells, although the expression of this gene is overall low
in C3 cells (Table S2). FAT4 is an activator of Hippo signalling in
Drosophila, but does not appear to regulate the Hippo pathway in
mammals [22].
RTqPCR confirmed that Kibra expression is reduced in dense
C3 cells and in fibrospheres (Fig. 5A). In contrast, its expression is
considerably higher in non-dense and dense C1 cells. These results
show that Kibra, a positive regulator of Hippo signalling is
strongly expressed in C1 cells, but is down regulated in dense C3
cells suggesting that the Hippo pathway is activated in dense C1
cells leading to contact inhibition, but not in C3 cells. RTqPCR
also confirmed low expression of Fat4 in dense and non-dense C3
cells as well as fibrospheres, whereas its expression is strongly
induced in dense C1 cells (Fig. 5A).
To determine whether reduced Kibra expression correlates with
Hippo signalling, we assessed cellular localisation of YAP1 and
TAZ by immunostaining of C1 and C3 cells. In low density
proliferating C1 cells, a clear nuclear staining for YAP1 is observed
(Fig. 5B). In contrast, in dense C1 cultures where proliferation is
arrested, YAP1 is now predominantly localised in the cytoplasm at
the plasma membrane. In proliferating C1 cells, TAZ is also
localised in the nucleus, whereas in dense cells, it remains in the
nucleus, but the signal becomes weaker and in many cells is almost
completely lost (Fig. S1A). These observations are consistent with
activation of Hippo signalling under dense conditions that leads
both to cytoplasmic localisation of YAP1, but also to proteolytic
degradation of TAZ [23].
In C3 cells a different profile is observed. In low-density C3
cells, YAP1 and TAZ are nuclear (Figs. 5B and Fig. S2A). In dense
C3 cells, TAZ remains nuclear, but its expression is reduced with
many cells showing little or no staining (Fig. S2A). In dense C3
cultures however, YAP1 is located in both the nucleus and
cytoplasm in cells that are dense, but not forming 3D foci. In
contrast, in cells forming 3D foci, strong YAP1 nuclear staining is
observed (Fig. 5C and Fig. S2C). Thus, down-regulation of Kibra
in dense C3 cells is associated with a strong increase in YAP1
nuclear localisation accounting for the lack of contact inhibition
and the observed 3D foci.
Wnt signalling is essential for 3D growth of C3 MEFs
To identify additional signalling pathways that may be involved
in promoting the 3D growth of C3 cells, we made a closer analysis
of the gene expression data. Examination of genes deregulated in
densely growing cells showed that expression of the Wnt9a ligand
was strongly up-regulated, while the Wnt antagonist Sfrp2 was
repressed (Table S2). RT-qPCR confirmed that Wnt9a expression
is strongly up-regulated in dense C3 cells and also showed its up-
regulation in fibrospheres that was not evidently seen by RNA-seq.
In contrast, Wnt9a is not induced in dense C1 cells (Fig. 6A).
Furthermore, basal Sfrp2 expression in low density C3 cells is
further reduced when cells become dense, whereas it is strongly
up-regulated in dense C1 cells (Fig. 6B). These data suggest that
up-regulation of the Wnt9a ligand and the reduction in Sfrp2
expression activates the Wnt pathway to promote 3D growth of
C3 cells, whereas in dense C1 cells Wnt signalling is attenuated
due to lack of Wnt9a induction and high Sfrp2 expression.
To test the role of Wnt signalling in 3D growth, we performed
shRNA knockdown of Wnt9a and tested the effect of chemical
inhibitors of this pathway. Wnt9a silencing with two independent
shRNAs (Fig. 6C) as well as treatment with the Wnt pathway
inhibitors IWR1 and XAV939 all reduced 3D foci formation
(Fig. 6D and data not shown). In each case, upon prolonged
growth, areas of high cell density form, but they do not develop
into full 3D foci as seen with untreated cells expressing a control
shRNA. Furthermore, each treatment also completely inhibited
fibrosphere formation (data not shown). These data show that Wnt
signalling plays a critical role in 3D growth of the C3 cells.
Cross-talk between the Hippo and Wnt signalling pathways has
been described. Hippo can negatively regulate Wnt signalling, for
example, through interactions of cytoplasmic TAZ with the
dishevelled proteins [24]. In contrast, in the absence of Hippo
signalling, nuclear YAP can associate with b-catenin (CTNNB1) to
promote expression of target genes such as SOX2 [25]. Formation
of 3D foci is associated with nuclear b-catenin staining as well as
nuclear YAP1 accumulation (Figs. 5C and 6E). A low expression
of SOX2 can be seen in both low and high-density C1 cells (Fig.
S1B). In low density C3 cells, SOX2 expression is heterogeneous,
with cells that express little or no SOX2, cells with intermediate
levels and rare cells with strong SOX2 staining (Fig. S2B). Under
dense conditions, SOX2 is strongly expressed in the cells that form
foci (Fig. 5C and Fig. S2B). Almost all cells in foci with strong
nuclear YAP1 staining also display strong SOX2 staining. In
control experiments and as expected, strong SOX2 staining is seen
in all nuclei of F9 embryonal carcinoma cells, but is absent from
hepatocyte cells demonstrating the specificity of this staining (Fig.
COL6A3 Regulates Hippo Signalling
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S1C). Treatment with the Wnt inhibitor XAV939 leads to a loss of
nuclear b-catenin staining (Fig. 6E), but has no effect on either
SOX2 or YAP1 expression or localisation (Fig. 6F). Thus,
inhibition of Wnt signalling does not lead to a loss of SOX2
expression suggesting that in these cells nuclear YAP1 alone is
sufficient to promote its expression as is seen in ES cells [26].
Together these results show that the conjugation of enhanced
Wnt signalling along with reduced Hippo signalling and nuclear
YAP1 accumulation is associated with 3D growth of a subpop-
ulation of C3 cells.
ATRA suppresses 3D growth of Taf42/2 MEFs
We have previously shown that ATRA treatment induces a
change in morphology of C3 cells that adopt a more regular
elongated shape [4]. ATRA treatment did not alter cell
proliferation. Growth kinetics performed by cell counting did
not show any significant difference between the untreated and
ATRA treated C3 cells (Fig. S3A). Similarly, ATRA treatment did
not lead to significant changes in BrdU incorporation over a 5 day
period (Fig. S3B). Finally ATRA treatment did not modify the cell
cycle as measured by FACS analysis (Fig. S3C). In particular, no
Figure 3. Comparative gene expression in C1 and C3 cells. A–I. Results of RT-qPCR analysis of the indicated genes in C1 or C3 cells grown for
3 and 10 days in monolayer cluture or 10 days as fibrospheres (F1 and F2).
doi:10.1371/journal.pone.0087365.g003
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significant G1/S arrest similar to what is seen with F9 or breast
cancer cells [27–29] is observed with the MEFs. ATRA does not
therefore inhibit 3D growth by inducing cell cycle arrest or
apoptosis of the C3 cells. Nevertheless, ATRA restores contact
inhibition attested by lack of 3D foci in monolayers (Fig. 7A) and
loss of fibrosphere growth (Fig. 7B). These results show that while
ATRA does not affect C3 cell growth under normal conditions, it
strongly reduces their 3D growth.
ATRA modulates expression of ECM components
3D growth of C3 cells involves enhanced Wnt signalling and
repressed Hippo signalling leading to changes in expression of a
large number of genes. We reasoned that expression of one or
several of these pathway/genes may be counteracted by ATRA
thus inhibiting 3D growth. We used RNA-seq to assay the changes
in gene expression after 12 hours of RA treatment to identify
mainly direct RAR targets and after 72 hours when the changes in
cell morphology become particularly evident to identify transcripts
that are induced or repressed under these conditions (Table S4).
After 72 hours of ATRA treatment only 80 genes showed a
three-fold or more increase in expression, 32 of which showed also
at least a three-fold increase after 12 hours (Table S4). 42
transcripts showed a three-fold or more down-regulation of which
8 were repressed at least three fold after 12 hours (Table S4).
Remarkably however, comparison of the genes whose expression is
up and down regulated upon 3D growth with those regulated by
ATRA reveals Col6a3 gene as almost the only potentially relevant
target. Indeed, Col6a3, whose expression is strongly induced upon
3D growth, is repressed after 72 hours of ATRA treatment (Table
S4). ATRA also down-regulates, but to a lesser extent other
collagens Col6a2, Col5a3 and Col7a1 showing that one of its major
effects in these cells is regulation of genes contributing to ECM
Figure 4. Elevated COL6A3 expression in MEFs growing as 3D foci. A. Immunostaining of dense C3 MEFs for COL6A3. Two distinct fields are
shown. COL6A3 is not homogeneously expressed, but strong expression is limited to the cells forming the 3D foci. B–C. Immunostaining of dense C3
cells expressing shRNAs directed against Col6a3 demonstrating the specificity of the staining.
doi:10.1371/journal.pone.0087365.g004
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modification. Repression of Col6a3 and Col6a2 expression there-
fore down regulates assembly of holo-collagen VI potentially
modulating the growth and clonogenic properties of C3 cells.
To examine the possible implication of Col6a3 in 3D cell growth,
we first verified by RT-qPCR that its expression was repressed by
ATRA. We examined the effect of ATRA on Col6a3 expression at
the time when its expression is induced in dense cells. C3 cells were
grown for 7 days in culture until dense, but before the appearance of
3D foci and then exposed to ATRA. After 12 hours of ATRA
treatment only a negligible reduction of expression was observed,
however after 24 hours a 3–4 fold reduction was observed (Fig. 7C).
A more potent reduction in Col6a3 expression was also seen after
72 hours of treatment when its expression is strongly up-regulated
without ATRA upon the formation of 3D foci. Interestingly, ATRA
also represses Col6a3 expression in TAF4-expressing C1 cells
(Fig. 7D). Hence, ATRA can repress the induction of Col6a3
Figure 5. Differential regulation of Hippo signalling in C1 and C3 MEFs. A Results of RT-qPCR analysis of the indicated genes in C1 or C3
cells grown for 3 and 10 days in monolayer culture, or 10 days as fibrospheres (F1). B Immunostaining of C1 and C3 MEFs for YAP1 at low or high
densities. C Immunostaining of C3 MEFs grown at high density for YAP1, SOX2 or b-catenin as indicated.
doi:10.1371/journal.pone.0087365.g005
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PLOS ONE | www.plosone.org 8 February 2014 | Volume 9 | Issue 2 | e87365
expression that takes place upon dense MEF growth, irrespective of
the presence or absence of TAF4.
COL6A3 silencing restores contact inhibition
The above results show a correlation between high expression of
COL6A3 in cells forming 3D foci, and the attenuation of this
strong expression when foci formation is abolished by ATRA.
However, these observations do not demonstrate that elevated
COL6A3 expression is essential for 3D growth. To address this
point, we used lentiviral shRNA vectors to suppress Col6a3
expression. Two independent shRNA-sequences showed a signif-
icant knockdown, strongly suppressing Col6a3 expression under
Figure 6. Wnt signalling is required for 3D growth. A–C. Results of RT-qPCR analysis of the indicated genes in C1 or C3 cells grown for 3 and 9–
10 days in monolayer cluture, 10 days as fibrospheres (F1 and F2) or in C3 cells expressing the indicated shRNAs. D Phase contrast microscopy (206
magnification) of C3 cells grown in presence or absence of the indicated Wnt pathway inhibitors or expressing control shRNA and shRNA directed
againt Wnt9a. E. Confocal microscopy sections through foci grown in the presence or absence of XAV939 showing that the nuclear b-catenin
localisation seen in the control C3 cells is lost in presence of XAV939. F. Immunostaining for YAP1 and SOX2 in foci in presence or absence of XAV939.
doi:10.1371/journal.pone.0087365.g006
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high density conditions (Fig. 8A). Strikingly, suppression of Col6a3
expression by both shRNAs abolished fibrosphere growth (Fig. 8B).
Moreover, shCol6a3 silencing leads to changes in cell morphology
very similar to those seen upon ATRA treatment. Upon
knockdown of Col6a3 expression or ATRA treatment, cells adopt
a more regular elongated shape and there was a complete loss of
3D foci formation (Fig. 8C). Strong Col6a3 expression is therefore
essential for formation of 3D foci, but also the general change in
morphology seen upon shRNA knockdown shows that even the
low basal Col6a3 expression in monolayer cells plays a role in
determining their morphology.
Examination of gene expression in dense shCol6a3 knockdown
cells showed little effect on many genes, such as Irf7 and the other
interferon response genes or Sned1, Fgf2 or Mgp, whose expression
was induced upon dense growth of both the control and shCol6a3
knockdown (Fig. S4 and data not shown). In contrast, expression
of other genes normally induced upon 3D growth such as Vav3 and
Blnk is strongly reduced upon Col6a3 knockdown (Fig. S4). These
observations distinguish genes whose expression is -up-regulated in
dense cultures of C3 cells and often (with the exception of the
interferon response genes) in dense C1 cells that are not dependent
on 3D growth, from genes whose expression is associated with 3D
growth and are not up-regulated in dense C1 cells.
Importantly, we also observed that Wnt9a expression was less
strongly induced in dense shCol6a3 cells than in normal dense C3
cells, but that Sfrp2 expression was strongly induced (Fig. 8D).
Moreover, we also found that Kibra expression was strongly
stimulated in the shCol6a3 cells (Fig. 8D). The elevated Kibra
expression seen in shCol6a3 cells suggests re-activation of Hippo
signalling to repress 3D growth. Low density shCol6a3 C3 cells
show nuclear staining for YAP1 and TAZ and heterogeneous
staining for SOX2 analogous to native C3 cells (Fig. 9A and S5A).
However, in agreement with the elevated Kibra expression, in
dense shCol6a3 C3 cells strongly reduced YAP1, TAZ and SOX2
expression is observed (Figs. 9B and S5B). Thus, elevated Col6a3
expression in dense C3 cells plays a critical role in repressing
Hippo signalling to promote 3D growth.
Discussion
Cross-talk between Col6a3, TAF4 and the Wnt and Hippo
pathways regulates 3D growth
In this study, we show that Col6a3 expression is up-regulated in
densely growing MEFs and that its high expression in Taf42/2
MEFs promotes loss of contact inhibition and their 3D growth
through modulation of the Hippo and Wnt pathways. It is
important to note that this phenotype is seen in the two
independent Taf42/2 MEF lines that we isolated and that re-
expression of exogenous TAF4 restores cell morphology and
promotes contact inhibition. Thus, all of the changes are directly
due to loss of TAF4 and can be reversed by its re-expression [4].
Col6a3 expression is induced in dense TAF4-expressing and
Taf42/2 MEFs. The high expression seen in the Taf42/2 MEFs
originates mainly from the small number of cells forming foci,
whereas in dense TAF4-expressing MEFs, expression is much
more homogeneous (data not shown). The ability of TAF4 to
counteract the growth promoting effects of high Col6a3 expression
can be evaluated by comparing the responses of the two cell types
under conditions of dense growth. In TAF4-expressing C1 cells,
YAP1 and TAZ are located in the nucleus as the cells proliferate at
low density. At high density, Kibra remains highly expressed,
while Fat4 expression is strongly induced. This suggests that Hippo
Figure 7. ATRA induced changes in properties of C3 MEFs. A. Phase contrast microscopy (206magnification) of C3 cells grown as dense
cultures for 3 days in presence or absence of ATRA. B. Phase contrast microscopy (126magnification) of C3 cells in grown for 10 days as fibrospheres
in presence or absence of ATRA. C–D Effect of ATRA on Col6a3 expression in C3 and C1 cells grown for the indicated number of days in presence or
absence of ATRA.
doi:10.1371/journal.pone.0087365.g007
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signalling is maintained in dense C1 cells to mediate contact
inhibition, an idea confirmed by the translocation of YAP1 from
the nucleus and the overall down-regulation of TAZ expression in
dense cultures.
In contrast, in the absence of TAF4, the pathways and factors
that normally maintain Kibra expression under dense conditions
are no longer operative and Kibra expression is repressed
attenuating Hippo signalling. Consequently, in dense Taf42/2
cells, YAP1 accumulates in the nucleus to promote 3D growth.
Kibra expression can be induced by YAP1 overexpression through
an as yet unknown mechanism [21]. Nevertheless, the transcrip-
tion factors and pathways that regulate Kibra expression in the C3
cells and that require TAF4 as a coactivator remain to be
determined. It is also interesting to note that FAT4 expression also
correlates with that of Hippo signalling despite the fact that
current evidence does not support a role for FAT4 in this pathway
Figure 8. Col6a3 is required for 3D MEF growth. A. RT-qPCR of Col6a3 expression in cells expressing control shRNA or two independent shRNAs
directed against Col6a3 after the indicated number of days in culture. B. Phase contrast microscopy (126magnification) of C3 cells expressing control
shRNA or shRNAs directed against Col6a3 grown for 10 days as fibrospheres. C. Phase contrast microscopy (206magnification) of C3 MEFs in the
presence and absence of ATRA showing the characteristic changes in cell morphology induced by RA and compared with C3 cells expressing shRNAs
directed against Col6a3. Col6a3 knockdown induces changes in cell morphology analogous to those seen in the presence of RA. D. Effects of Col6a3
silencing on gene expression.
doi:10.1371/journal.pone.0087365.g008
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in mammals where it is rather a critical regulator of the planar cell
polarity pathway [30]. The role, if any, that TAF4 control of
FAT4 expression may play in modulating the growth of C1 and
C3 MEFs remains to be investigated.
Several lines of evidence indicate that Wnt signalling is also
involved in 3D growth of Taf42/2 MEFs. In dense Taf42/2
MEFs, Wnt9a expression is strongly up-regulated while Sfrp2
expression is repressed. The nuclear localisation of b-catenin in the
cells forming 3D foci shows enhanced Wnt signalling in these cells.
Also shRNA-mediated Wnt9a silencing or use of chemical
inhibitors of Wnt signalling abrogates 3D growth indicating the
critical role of the pathway in this process. Interestingly, ChIP-seq
has revealed SOX2 [31] and YAP1 [26] binding close to the
Wnt9a gene. This suggests that YAP1 and SOX2 in dense C3 cells
may activate Wnt9a expression in a positive feed forward loop to
promote 3D growth. This contrasts with the TAF4-expressing
MEFs, where Wnt9a expression is not induced under dense
conditions, but Sfrp2 expression is strongly induced. Consequently,
in dense TAF4-expressing MEFs, Wnt signalling is repressed, the
opposite of what is observed in Taf42/2 MEFs. The loss of TAF4
Figure 9. Reactivation of Hippo signalling upon Col6a3 silencing. A. Expression of YAP1 and SOX2 in low-density shCol6a3 knockdown cells
grown for 2 days as monolayers. Cells expressing low or high levels of SOX2 are indicated by arrows. B. Expression of YAP1 and SOX2 expression in
dense shCol6a3 silenced cells grown for 8 days as monolayers. Col6a3 silencing leads to diminished YAP1 and SOX2 expression.
doi:10.1371/journal.pone.0087365.g009
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therefore modifies Wnt9a and Sfrp expression to activate Wnt
signalling in conditions of high density to promote 3D growth.
Together our results support a model where loss of contact
inhibition through diminished Hippo signalling allows the cells to
form dense foci, while enhanced Wnt signalling is further required
for full 3D growth. It is also interesting to note that high SOX2
expression is seen already in rare nuclei of low-density C3 cells.
Thus TAF4 inactivation leads to heterogeneity in the cell
population suggesting that it is the SOX2 high population that
is competent to generate 3D foci under dense conditions.
Retinoic acid regulates MEF growth via repression of
Col6a3
The capacity of Taf42/2 MEFs for 3D growth appears to be
associated with high Col6a3 expression. The expression of several
membrane and ECM components is strongly induced in dense
conditions. Nevertheless, shRNA mediated silencing of Col6a3
alone is sufficient to abolish 3D growth. Further evidence for a
critical role of Col6a3 in 3D growth comes from the observation
that its expression is down-regulated by ATRA that restores
contact inhibition and represses 3D growth. ATRA down-
regulates both Col6a3 and to a lesser extent Col6a2, thereby
down-regulating holo-collagen VI fibre formation. While the
expression of many membrane and ECM components are strongly
induced by 3D growth, Col6a3 is one of the few regulated by
ATRA and is the most strongly repressed. Moreover, ATRA
treatment does not affect expression of known components of the
Hippo pathway and may even potentiate Wnt signalling through
up-regulation of Wnt9a. These observations, together with the
results of Col6a3 silencing, indicate that the major mechanism by
which ATRA inhibits 3D growth is through repression of Col6a3.
The growth suppressive effect of ATRA on these cells by
regulation of ECM components is therefore fundamentally
different from that seen in F9 embryonal carcinoma cells, HL60
myeloid cells, or mammary carcinoma cells where RA treatment
induces cell cycle arrest, differentiation and under some conditions
apoptosis [28,29,32,33].
ECM components such as COL6A3 can provide a network that
physically facilitates 3D growth. While the reduction in this
network in the presence of ATRA may contribute to its ability to
repress 3D growth, remodelling the ECM does not appear to be
the only role of COL6A3 as it’s silencing also dramatically
modulates gene expression and signalling. ShCol6a3 silencing
stimulates expression of Kibra and re-activates Hippo signalling
leading to reduced YAP1 expression. These observations show
that Col6a3 plays an active role in modulating expression of growth
control genes and are in line with previous results showing that
high Col6a3 expression modulates cell and tumour growth.
Ovarian cancer cells resistant to cisplatin show a potent induction
of the Col6a3 gene and in vivo, high grade tumours express higher
levels of Col6a3 than low grade tumours [13]. Similarly, Col6a3 is
up-regulated in the stroma of colon tumours [34], and promotes
the development of hyperplastic foci and primary tumour growth
in breast cancer models by activating pro-survival and prolifera-
tion pathways involving, as seen here, b-catenin [12]. Collagen VI
has also been shown to promote cell cycle progression and anti-
apoptotic pathways in serum-starved fibroblasts and in corneal
derived fibroblasts [35,36]. Our data extend these observations
showing how Col6a3 can modulate expression of critical regulators
of the Hippo and Wnt pathways to promote growth and how it
can serve as a target for ATRA mediated suppression of growth.
Together the results described here reveal a novel and complex
interplay between at least three signalling pathways (Hippo, Wnt
and ATRA) that control 3D fibroblast growth. We describe the
ability of TAF4 to control expression of critical components of the
Hippo and Wnt pathways and a novel role of COL6A3 as ATRA-
regulated modulator of 3D growth and as regulator of gene
expression.
Supporting Information
Figure S1 Expression and localisation of TAZ and SOX2
in C1 MEFs. A. Immunostaining of non-dense and dense C1
MEFs for TAZ. B. Immunostaining of non-dense and dense C1
MEFs for SOX2 (206magnification). C. Control staining of F9
embryonal carcinoma cells and of hepatocyte cells with SOX2
antibody to demonstrate the specificity of the signal.
(PDF)
Figure S2 Expression and localisation of TAZ, YAP1 and
SOX2 in C3 MEFs. A. Immunostaining of non-dense and dense
C3 MEFs for TAZ. B. Immunostaining of low density C3 cells
with YAP1 and SOX2 antibody (206 magnification). Cells
expressing low or high levels of SOX2 are indicated by arrows.
C Immunostaining of dense C3 MEFs for YAP1 and SOX2 (206
magnification). The location of cells growing in a 3D foci is
indicated.
(PDF)
Figure S3 A. Effect of RA on C3 cell proliferation. A.
Kinetics of cell growth in presence or absence of RA as evaluated
by cell counting. B. Assessment of cell division by incorporation of
BrdU on cells grown for the indicated periods in presence or
absence of RA. C. Results of a representative FACS assay showing
the % cells in each stage of cell cycle. D. Clonogenic assays of C3
cells in presence or absence of ATRA or shCol6a3 on wells coated
with fibronectin.
(PDF)
Figure S4 Effect of shCol6a3 knockdown on gene
expression. RT-qPCR on the indicated genes in C3 cells
expressing control shRNA or shRNA directed against Col6a3
grown for 3 or 10 days as indicated.
(PDF)
Figure S5 Expression of TAZ in shCol6a3 knockdown
cells. A. Expression of TAZ in low-density shCol6a3 knockdown
cells. B Expression of TAZ in high density shCol6a3 knockdown
cells.
(PDF)
Table S1 Sequences of primers used for qPCR of the
indicated genes on the forward and reverse strands.
(DOC)
Table S2 Excel table of RNA-seq results. Page 1 shows
transcripts induced in dense conditions. Shown are, the
Ensembl gene ID, the average RPKM expression values under
each condition, the fold change and Log2 change values under the
indicated conditions, gene name and description. Pages 2–4 show
the same information concerning transcripts induced in spheres,
repressed under dense conditions and repressed in spheres
respectively.
(XLS)
Table S3 Ontology analyses of genes whose expression
is modified under conditions of dense or 3D growth.
Each page shows the analysis of genes differentially regulated
under the specified conditions with the indicated ontology terms.
(XLS)
Table S4 Genes regulated by ARTA in C3 MEFs. Pages 1
and 2 show the induced and repressed genes after 12 and 72 hours
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of ATRA treatment. Shown are the Ensembl gene IDs, gene
name, log2 ratios 2ATRA/+ATRA 12 hours, 2ATRA/+ATRA
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